Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $302.61 | 8 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $124.99 | 1 | $0 (2017) |
| Millennium Pharmaceuticals, Inc. | $75.03 | 1 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $53.59 | 3 | $0 (2017) |
| Lilly USA, LLC | $23.42 | 1 | $0 (2017) |
| Incyte Corporation | $15.04 | 1 | $0 (2017) |
| Helsinn Therapeutics (U.S.), Inc. | $10.54 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2017 | $302.61 | 8 | AstraZeneca Pharmaceuticals LP ($124.99) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/13/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/07/2017 | Millennium Pharmaceuticals, Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $75.03 | General |
| Category: Oncology | ||||||
| 04/06/2017 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $15.04 | General |
| Category: Hematology/Oncology | ||||||
| 03/31/2017 | Helsinn Therapeutics (U.S.), Inc. | AKYNZEO (Drug), ALOXI | Food and Beverage | In-kind items and services | $10.54 | General |
| Category: ONCOLOGY | ||||||
| 03/10/2017 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: ONCOLOGY | ||||||
| 02/17/2017 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: ONCOLOGY | ||||||
| 01/27/2017 | Merck Sharp & Dohme Corporation | EMEND (Drug), KEYTRUDA | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: ONCOLOGY | ||||||
| 01/20/2017 | Lilly USA, LLC | CYRAMZA (Drug) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: Oncology | ||||||
About Dr. Shanta Bajaj, MD
Dr. Shanta Bajaj, MD is a Hematology & Oncology healthcare provider based in Forest Hills, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659326809.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shanta Bajaj, MD has received a total of $302.61 in payments from pharmaceutical and medical device companies, with $302.61 received in 2017. These payments were reported across 8 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($302.61).
Practice Information
- Specialty Hematology & Oncology
- Location Forest Hills, NY
- Active Since 05/24/2006
- Last Updated 10/05/2011
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1659326809
Products in Payments
- FARXIGA (Drug) $124.99
- NINLARO (Drug) $75.03
- KEYTRUDA (Biological) $38.44
- CYRAMZA (Drug) $23.42
- EMEND (Drug) $15.15
- JAKAFI (Drug) $15.04
- AKYNZEO (Drug) $10.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Forest Hills
Ewa Matczak, Md, MD
Hematology & Oncology — Payments: $287,791
Dr. Vladimir Gotlieb, Md, MD
Hematology & Oncology — Payments: $85,447
Jane Daly, Md, MD
Hematology & Oncology — Payments: $8,156
Dr. Dhvani Thakker, M.d, M.D
Hematology & Oncology — Payments: $2,416
David Askin, D.o, D.O
Hematology & Oncology — Payments: $1,249
George Spanos, Md, MD
Hematology & Oncology — Payments: $378.13